Showing results (121-130 of 177) with videos related to

Sort By:
Pageof 18
Clinical Pharmacology and Therapeutics|May 8, 2019
Healthy User Bias in Comparative Safety Studies for Brand-Name vs. Generic Products: The Example of WarfarinSteven T Bird, Natasha Flowers, Yueqin Zhao, et al.
Contraception|October 23, 2012
Recent combined hormonal contraceptives (CHCs) and the risk of thromboembolism and other cardiovascular events in new usersStephen Sidney, T Craig Cheetham, Frederick A Connell, et al.
Pharmacoepidemiology and Drug Safety|February 16, 2024
Dispensing pharmacy chains and direct anticoagulants: Potential associations with patient outcomesSteven Kozlowski, Ellen Tworkoski, Sai Dharmarajan, et al.
Pharmacoepidemiology and Drug Safety|January 21, 2012
A protocol for active surveillance of acute myocardial infarction in association with the use of a new antidiabetic pharmaceutical agentBruce Fireman, Sengwee Toh, Melissa G Butler, et al.
Regional Anesthesia and Pain Medicine|December 5, 2020
Risk of serious spinal adverse events associated with epidural corticosteroid injections in the Medicare populationEfe Eworuke, Leah Crisafi, Jiemin Liao, et al.
The Journal of Infectious Diseases|October 7, 2021
Risk Factors for COVID-19 Deaths Among Elderly Nursing Home Medicare Beneficiaries in the Prevaccine PeriodYun Lu, Yixin Jiao, David J Graham, et al.
Diabetes Care|February 21, 2020
Similar Breast Cancer Risk in Women Older Than 65 Years Initiating Glargine, Detemir, and NPH InsulinsMarie C Bradley, Yoganand Chillarige, Hana Lee, et al.
Addiction (Abingdon, England)|July 21, 2012
Neuropsychiatric events in varenicline and nicotine replacement patch users in the Military Health SystemTamra E Meyer, Lockwood G Taylor, Suji Xie, et al.
The Journal of Infectious Diseases|December 16, 2020
Natural History of Coronavirus Disease 2019: Risk Factors for Hospitalizations and Deaths Among >26 Million US Medicare BeneficiariesHector S Izurieta, David J Graham, Yixin Jiao, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 28, 2013
Cardiovascular and mortality risks in Parkinson's disease patients treated with entacaponeDavid J Graham, James R Williams, Ya-Hui Hsueh, et al.
Pageof 18